BioSpace News Archive

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) (“ScreenPro” or the “Company”) is pleased to announce that further to the news release on September 8, 2022, announcing the management and board changes, the Company would like to provide the following corporate updates.

Awakn Life Sciences Corp., a revenue-generating biotechnology company researching, developing, and commercializing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), today announces it has signed a drug development agreement with Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities.

Pfizer Inc. and BioNTech SE announced a 30-µg booster dose of their Omicron BA.4/BA.5 bivalent-adapted COVID-19 vaccine has been recommended for conditional marketing authorization by the European Medicines Agency’s Committee for Medicinal Products for Human Use for individuals ages 12 years and older.

Duplex Sequencing is a commonly used technique to improve DNA sequencing accuracy.

The induced pluripotent stem cells production market has been estimated to reach a CAGR of 8.0% in the foreseeable years from 2021 to 2031.

Acute kidney injury can be described as partial or full loss of kidney function because of sudden damage to the organ.

Inventive technologies and cutting-edge research have led to the development of several innovative magnetic resonance imaging equipment, helping patients live healthier and longer lives.

Antibodies are defined as the host proteins created by human body as a reaction after the entry of foreign molecules or foreign bodies in the body.

Biosimilar is referred to a medical product that is similar to existing drug produced by a well-established company.

The outbreak of novel coronavirus in 2020 has created a massively increased demand for precise treatment and diagnostic devices in the global healthcare industries.